Literature DB >> 27208168

Releasing the brakes in coagulation Factor IXa by co-operative maturation of the substrate-binding site.

Line Hyltoft Kristensen1, Ole H Olsen2, Grant E Blouse3, Hans Brandstetter4.   

Abstract

Coagulation Factor IX is positioned at the merging point of the intrinsic and extrinsic blood coagulation cascades. Factor IXa (activated Factor IX) serves as the trigger for amplification of coagulation through formation of the so-called Xase complex, which is a ternary complex of Factor IXa, its substrate Factor X and the cofactor Factor VIIIa on the surface of activated platelets. Within the Xase complex the substrate turnover by Factor IXa is enhanced 200000-fold; however, the mechanistic and structural basis for this dramatic enhancement remains only partly understood. A multifaceted approach using enzymatic, biophysical and crystallographic methods to evaluate a key set of activity-enhanced Factor IXa variants has demonstrated a delicately balanced bidirectional network. Essential molecular interactions across multiple regions of the Factor IXa molecule co-operate in the maturation of the active site. This maturation is specifically facilitated by long-range communication through the Ile(212)-Ile(213) motif unique to Factor IXa and a flexibility of the 170-loop that is further dependent on the conformation in the Cys(168)-Cys(182) disulfide bond. Ultimately, the network consists of compensatory brakes (Val(16) and Ile(213)) and accelerators (Tyr(99) and Phe(174)) that together allow for a subtle fine-tuning of enzymatic activity.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  coagulation Factor IX; conformational changes; crystal structure; enzyme kinetics; substrate-binding site; thermal shift assay

Mesh:

Substances:

Year:  2016        PMID: 27208168     DOI: 10.1042/BCJ20160336

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

1.  Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity.

Authors:  Benjamin J Samelson-Jones; Jonathan D Finn; Lindsey A George; Rodney M Camire; Valder R Arruda
Journal:  JCI Insight       Date:  2019-06-20

2.  Exosites expedite blood coagulation.

Authors:  Maria Luiza Vilela Oliva; Ingrid Dreveny; Jonas Emsley
Journal:  J Biol Chem       Date:  2020-11-06       Impact factor: 5.157

3.  Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.

Authors:  Han Fang; Thomas Zögg; Hans Brandstetter
Journal:  FEBS Open Bio       Date:  2019-07-02       Impact factor: 2.693

4.  Sirtilins - the new old members of the vitamin K-dependent coagulation factor family.

Authors:  Sven O Dahms; Fatih Demir; Pitter F Huesgen; Karina Thorn; Hans Brandstetter
Journal:  J Thromb Haemost       Date:  2019-02-13       Impact factor: 5.824

5.  A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice.

Authors:  Henrik Østergaard; Jacob Lund; Per J Greisen; Stine Kjellev; Anette Henriksen; Nikolai Lorenzen; Eva Johansson; Gustav Røder; Morten G Rasch; Laust B Johnsen; Thomas Egebjerg; Søren Lund; Henrik Rahbek-Nielsen; Prafull S Gandhi; Kasper Lamberth; Mette Loftager; Lisbeth M Andersen; Amalie C Bonde; Fabian Stavenuiter; Daniel E Madsen; Xun Li; Thomas L Holm; Carsten D Ley; Peter Thygesen; Haisun Zhu; Rong Zhou; Karina Thorn; Zhiru Yang; Mette B Hermit; Jais R Bjelke; Bjarne G Hansen; Ida Hilden
Journal:  Blood       Date:  2021-10-07       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.